Xiaoping Jin Selected Research

Xiaoping Jin Research Topics

Disease

8	Neoplasms (Cancer) 10/2022 - 12/2013
5	Type 2 Diabetes Mellitus (MODY) 01/2015 - 09/2009
4	Carcinoma (Carcinomatosis) 01/2020 - 09/2017
3	Diabetic Nephropathies (Diabetic Nephropathy) 10/2022 - 01/2020
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2019 - 10/2016
3	Atherosclerosis 10/2018 - 12/2015
3	Prediabetic State (Prediabetes) 07/2010 - 09/2009
2	Stroke (Strokes) 12/2022 - 01/2018
2	Neoplasm Metastasis (Metastasis) 11/2019 - 01/2018
2	Ischemic Stroke 06/2016 - 12/2015
2	Thyroid Diseases (Thyroid Disease) 08/2015 - 01/2015
2	Cerebral Infarction 12/2014 - 08/2014
2	Hypercholesterolemia 07/2010 - 07/2010
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 10/2022
1	Cardiotoxicity 04/2022
1	Acute Coronary Syndrome 01/2022
1	Inflammation (Inflammations) 01/2020
1	Fibrosis (Cirrhosis) 01/2020
1	Lung Neoplasms (Lung Cancer) 11/2019
1	Hepatocellular Carcinoma (Hepatoma) 05/2019
1	Squamous Cell Carcinoma of Head and Neck 10/2016
1	Urinary Bladder Neoplasms (Bladder Cancer) 10/2016
1	Sensorineural Hearing Loss 02/2015
1	Deafness (Deaf Mutism) 02/2015
1	Hearing Loss (Hearing Impairment) 02/2015
1	Vitamin D Deficiency 01/2015
1	Autoimmune Diseases (Autoimmune Disease) 01/2015
1	Hypertension (High Blood Pressure) 08/2014
1	Edema (Dropsy) 12/2013
1	Pancreatic Neoplasms (Pancreatic Cancer) 12/2013
1	Fatigue 12/2013
1	Nausea 12/2013
1	Hyperlipidemias (Hyperlipidemia) 11/2009
1	Glucose Intolerance 09/2009
1	Hyperglycemia 09/2009
1	Human Influenza (Influenza) 11/2007

Drug/Important Bio-Agent (IBA)

7	durvalumabIBA 01/2020 - 10/2016
4	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 09/2009
4	Monoclonal AntibodiesIBA 01/2019 - 12/2013
4	LDL CholesterolIBA 07/2010 - 09/2009
4	LipidsIBA 07/2010 - 09/2009
4	Colesevelam Hydrochloride (Welchol)FDA Link 07/2010 - 09/2009
3	diphenyl (biphenyl)IBA 10/2022 - 01/2020
3	InflammasomesIBA 10/2022 - 01/2020
3	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2018
3	ParaffinIBA 01/2019 - 10/2016
3	Formaldehyde (Formol)FDA Link 01/2019 - 10/2016
3	oxidized low density lipoproteinIBA 07/2010 - 11/2009
2	Pharmaceutical PreparationsIBA 12/2022 - 09/2009
2	Immune Checkpoint InhibitorsIBA 10/2022 - 10/2016
2	LigandsIBA 11/2019 - 10/2016
2	Matrix Metalloproteinases (MMPs)IBA 10/2018 - 12/2014
2	Hemoglobins (Hemoglobin)IBA 01/2018 - 07/2010
2	Proteins (Proteins, Gene)FDA Link 01/2018 - 11/2007
2	AlbuminsIBA 01/2018 - 01/2018
2	Triglycerides (Triacylglycerol)IBA 08/2014 - 07/2010
2	Metformin (Glucophage)FDA LinkGeneric 07/2010 - 09/2009
1	Immunoglobulin G (IgG)IBA 10/2022
1	penpulimabIBA 10/2022
1	MicroRNAs (MicroRNA)IBA 04/2022
1	Doxorubicin (Adriamycin)FDA LinkGeneric 04/2022
1	Plasma GasesIBA 01/2022
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2022
1	B7-H1 AntigenIBA 01/2020
1	alpha-Fetoproteins (alpha-Fetoprotein)IBA 05/2019
1	Tissue Inhibitor of MetalloproteinasesIBA 10/2018
1	EnzymesIBA 01/2018
1	ImmunosorbentsIBA 01/2018
1	PlatinumIBA 01/2018
1	PeriostinIBA 01/2018
1	Neuregulin-1 (Neuregulin 1)IBA 01/2017
1	patritumabIBA 01/2017
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2017
1	histidine-rich proteinsIBA 01/2017
1	ThrombospondinsIBA 12/2015
1	DisintegrinsIBA 12/2015
1	Peptide Hydrolases (Proteases)FDA Link 12/2015
1	AntibodiesIBA 08/2015
1	IodineIBA 08/2015
1	Transfer RNA (tRNA)IBA 02/2015
1	Phe Transfer RNAIBA 02/2015
1	Vitamin D FDA LinkGeneric 01/2015
1	Fatty Acid-Binding ProteinsIBA 01/2015
1	Tissue Inhibitor of Metalloproteinase-3IBA 12/2014
1	Matrix Metalloproteinase 14 (MT1-MMP)IBA 08/2014
1	TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA 12/2013
1	Gemcitabine FDA Link 12/2013
1	CaspasesIBA 12/2013
1	tigatuzumabIBA 12/2013
1	Bile Acids and Salts (Bile Acids)IBA 07/2010
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 09/2009
1	Lipoproteins (Lipoprotein)IBA 09/2009
1	Sialic AcidsIBA 11/2007
1	oplunofuspIBA 11/2007
1	Neuraminidase (Sialidase)IBA 11/2007
1	Antiviral Agents (Antivirals)IBA 11/2007

Therapy/Procedure

6	Therapeutics 01/2018 - 09/2009
3	Drug Therapy (Chemotherapy) 01/2018 - 09/2009
1	Immunotherapy 01/2018
1	Glycemic Control 11/2009